• 2017 Patent Law Year in Review Highlights

    McDermott’s annual Patent Law Year in Review covered topics ranging from: patent eligibility subject matter, anticipation, obviousness, claim constructio.

     
  • Extrinsic Evidence Can Be Used to Support Inherent Anticipation

    The US Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) finding that the challenged claims were anticipated and obvious. Monsanto Tech. LLC v. E.I. DuPont de Nemours & Co., Case No. 17-1032 (Fed. Cir., Jan. 5, 2018) (Wallach, J). Regarding the anticipation …

     
  • Apportionment Must Reflect No More than Invention’s Incremental Value

    The Federal Circuit affirmed the jury’s infringement finding for two of the three patents appealed, but concluded that Blue Coat was entitled to judgment as a matter of law of non-infringement for the third patent. As for the damages award, Blue Coat argued that Finjan failed to appropriately apportion …

     
  • Online Filing software – new update now available

    http://www.epo.org/service-support/updates/2018/20180301.html Content reproduced from the Website of the European Patent Office as permitted by their terms of use.

     
  • Validation agreement with Cambodia enters into force

    http://www.epo.org/news-issues/news/2018/20180301.html Content reproduced from the Website of the European Patent Office as permitted by their terms of use. European patents granted by the EPO and validated in Cambodia will have the same legal effects as a corresponding Cambodian patent and will be subject to Cambodian patent law.

     
  • European patent law

    The future of the Unitary Jan 21, 2016 · European patent law European patent law covers a wide range of legislations including national patent laws, the Strasbourg Convention of 1963, the European European Patent Attorneys are This information is simplified and must not be taken as a definitive …

     
  • Cleveland Clinic – Time to Purport an Inventive Concept in a Diagnostic Invention?

    ‘[T]he claims instruct that MPO levels be detected or determined using any of these known techniques. The claims of the testing patent also contain a comparing step where MPO levels are compared to statistically derived control or predetermined values. Here too, the Cleveland Clinic does not purport to …

     
  • University of Michigan Law Professor Rebecca Eisenberg to present Nies Lecture in Intellectual

    MILWAUKEE — Rebecca Eisenberg, a professor at the University of Michigan Law School, will present “Opting for Regulation When Patentability Is in Doubt” for Marquette Law School’s Nies Lecture in Intellectual Property on Tuesday, March 6, at 4:30 p.m. in Eckstein Hall’s Lubar Center. Eisenberg …

     
  • Patents, Giffen Goods, Invitations

    Another professor, Dr. Zach Donohew, and I have discussed patent law and whether or not it is necessary for future development of lifesaving drugs. He argues that if R&D for a drug is very expensive, but the drug can be widely manufactured by anyone in the absence of patent law,... Continue reading

     
  • King & Spalding Nabs Cooley’s Ex-IP Litigation Head

    Law360 (February 28, 2018, 4:32 PM EST) — King & Spalding LLP has hired the former head of Cooley LLP’s intellectual property litigation group who has represented technology and life sciences companies in high-stakes disputes over patents, trademarks, copyrights and trade secrets in courts and …